Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 210

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

The aflatoxin B 1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma

Open access
Smela, Maryann E., Hamm, Michelle L., Henderson, Paul T., Harris, Constance M., Harris, Thomas M., Essigmann, John M. · 2002 · Proceedings of the National Academy of Sciences

Abstract

A G to T mutation has been observed at the third position of codon 249 of the p53 tumor-suppressor gene in over 50% of the hepatocellular carcinoma cases associated with high exposure to aflatoxin B 1 (AFB 1 ). Hypotheses have been put forth that AFB 1 , in concert with hepatitis B virus (HBV), may play a role in the formation of, and/or the selection for, this mutation. The primary DNA adduct of AFB 1 is 8,9-dihydro-8-( N 7 -guanyl)-9-hydroxyaflatoxin B 1 (AFB 1 -N7-Gua), which is converted naturally to two secondary lesions, an apurinic site and an AFB 1 -formamidopyrimidine (AFB 1 -FAPY) adduct. AFB 1 -FAPY is detected at near maximal levels in rat DNA days to weeks after AFB 1 exposure, underscoring its high persistence in vivo . The present study reveals two striking properties of this DNA adduct: ( i ) AFB 1 -FAPY was found to cause a G to T mutation frequency in Escherichia coli approximately 6 times higher than that of AFB 1 -N7-Gua, and ( ii ) one proposed rotamer of AFB 1 -FAPY is a block to replication, even when the efficient bypass polymerase MucAB is used by the cell. Taken together, these characteristics make the FAPY adduct the prime candidate for both the genotoxicity of aflatoxin, because mammalian cells also have similar bypass mechanisms for combating DNA damage, and the mutagenicity that ultimately may lead to liver cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.102167699

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 210

Metadata

Authors
Smela, M. E., Hamm, M. L., Henderson, P. T., Harris, C. M., Harris, T. M., & Essigmann, J. M.
Venue
Proceedings of the National Academy of Sciences
Published
2002-05-14
Volume
99
Issue
10
Pages
6655-6660
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2135272393
Cited by
210
References
1
FWCI
2.99
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The aflatoxin B 1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. https://app.cochat.ai/papers/10.1073/pnas.102167699
The paper
Smela, M. E., Hamm, M. L., Henderson, P. T., Harris, C. M., Harris, T. M., & Essigmann, J. M. (2002). The aflatoxin B 1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.102167699

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.